 | | Management van diabetes & ACS-Cardiovasculair perspectief |
|  | | Diabetes is………. |
|
 | | role of the A1C assay in the diagnosis of diabetes |
|  | | Diabetes Risk for Early MI Mortality |
|
 | | Hyperglycaemia |
|  | | Adverse Cardiometabolic Effects of Visceral Adipocytes |
|
 | | Natuurlijk beloop van type 2 Diabetes |
|  | | Insulin Resistance |
|
 | | T2DM Exacerbates Vascular Wall Disease |
|  | | Chronic Diabetes Consequences |
|
 | | Intensive Glycemic Control and CVD Outcomes |
|  | | Early vs Late Glycaemic Intervention |
|
 | | Mortality in ACS : Diabetes vs no Diabetes |
|  | | Impact of Revascularization: Euro-Heart Survey |
|
 | | SYNTAX |
|  | | choice of revascularization strategy in diabetic patients. |
|
|  | | PLATO diabetes |
|
 | | Primary endpoint |
|  | | Diabetes |
|
 | | Reduction in risk (%) |
|  | | diabetes mellitus as independent predictor of drug-eluting stent thrombosis. |
|
 | | Hyperglycaemie & mortaliteit bij AMI |
|  | | Major Trials of GIK in AMI |
|
 | | Glycemia Focus Strategy |
|  | | PROVE-IT |
|
 | | Relationship between LDL-C and CV Event Rate |
|  | | Major Vascular Events |
|
 | | Risk of Coronary Death or Myocardial Infarction |
|  | | Recommendations for Treatment Targets for LDL-C |
|
 | | the STENO-2 Study – 13 Years of Follow-up |
|  | | STENO-2 |
|
 | | Ten important recommendations |
|  | | Ten important recommendations |
|
Deel deze pagina met collega's en vrienden: